EMA Authorised: Zegalogue (dasiglucagon hydrochloride) — Zealand Pharma A/S

View source ↗

Summary

The EMA has authorised Zegalogue (dasiglucagon hydrochloride) from Zealand Pharma A/S for the emergency treatment of severe hypoglycaemia in people with diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypoglycemia

Drugs mentioned

• Zegalogue (dasiglucagon)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus. MAH: Zealand Pharma A/S. Decision date: 19/01/2026